... Organic Process Research & Development. ... GlaxoSmithKline R&D, Chemical Development, Synthetic Chemistry ... Interestingly, only 11% of the combined mass of these reagents ends up as part of the structure in 19, rendering the atom economy of the process extremely poor. ...